edaravone
AssetAlso MCI-186, NSC-12, NSC-26139, NSC-2629
Free radical scavenger reducing oxidative stress in neurons.
- Stage
- Approved
- Modality
- Small molecule
- Target
- Oxidative stress and ROS signalling
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Amyotrophic lateral sclerosis
Approved, genengnews.com, 6 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners2
- Evidence for its targets1
- Competitors12
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.